Advanced search
Publication Cover
Current Medical Research and Opinion Volume 35, 2019 - Issue 5
Submit an article Journal homepage
5,294
Views
11
CrossRef citations to date
0
Altmetric
Gastroenterology

Treatment sequence network meta-analysis in Crohn’s disease: a methodological case study

Abhishek VaruEvidence Synthesis, Cornerstone Research Group, Burlington, Ontario, Canada;
,
Florence R. WilsonEvidence Synthesis, Cornerstone Research Group, Burlington, Ontario, Canada;
,
Peter DyrdaJanssen Inc., Janssen Canada, Toronto, Ontario, Canada;
,
Maureen HazelJanssen Inc., Janssen Canada, Toronto, Ontario, Canada;
,
Brian HuttonEvidence Synthesis, Cornerstone Research Group, Burlington, Ontario, Canada; ;Research, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; ;Public Health and Preventative Medicine, University of Ottawa School of Epidemiology, Ottawa, Ontario, Canada
&
Chris CameronEvidence Synthesis, Cornerstone Research Group, Burlington, Ontario, Canada; Correspondence[email protected]
Pages 733-756 | Received 19 Nov 2018, Accepted 05 Feb 2019, Published online: 20 Mar 2019

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Vipul Jairath, Keith Chan, Karen Lasch, Sam Keeping, Christian Agboton, Aimee Blake & Haridarshan Patel. (2021) Integrating efficacy and safety of vedolizumab compared with other advanced therapies to assess net clinical benefit of ulcerative colitis treatments: a network meta-analysis. Expert Review of Gastroenterology & Hepatology 15:6, pages 711-722.
Read now
Margaux Welty, Laura Mesana, Amie Padhiar, Dominik Naessens, Joris Diels, Suzy van Sanden & Maud Pacou. (2020) Efficacy of ustekinumab vs. advanced therapies for the treatment of moderately to severely active ulcerative colitis: a systematic review and network meta-analysis. Current Medical Research and Opinion 36:4, pages 595-606.
Read now

Articles from other publishers (9)

Rose J. Hart, Fareen Hassan, Sarah Alulis, Karl W. Patterson, Jennifer Norma Barthelmes, Jennifer H. Boer & Dawn Lee. (2024) Modelling Treatment Sequences in Immunology: Optimizing Patient Outcomes. Advances in Therapy 41:5, pages 2010-2027.
Crossref
Carl Eriksson, Jonas Söderling, Sara Karlqvist, Gabriella Bröms, Åsa H. Everhov, Daniel Bergemalm, Jonas F. Ludvigsson, Ola Olén & Jonas Halfvarson. (2023) Ustekinumab Versus Anti-tumour Necrosis Factor Alpha Agents as Second-Line Biologics in Crohn's Disease. Digestive Diseases and Sciences 68:7, pages 3119-3128.
Crossref
Boran Yu, Libo Zhao, Siyao Jin, Huan He, Jing Zhang & Xiaoling Wang. (2022) Model-Based Meta-Analysis on the Efficacy of Biologics and Small Targeted Molecules for Crohn’s Disease. Frontiers in Immunology 13.
Crossref
Laurène Parrot, Catherine Dong, Franck Carbonnel & Antoine Meyer. (2021) Systematic review with meta‐analysis: the effectiveness of either ustekinumab or vedolizumab in patients with Crohn's disease refractory to anti‐tumour necrosis factor. Alimentary Pharmacology & Therapeutics 55:4, pages 380-388.
Crossref
Javier P. Gisbert & María Chaparro. (2021) Primary Failure to an Anti-TNF Agent in Inflammatory Bowel Disease: Switch (to a Second Anti-TNF Agent) or Swap (for Another Mechanism of Action)?. Journal of Clinical Medicine 10:22, pages 5318.
Crossref
Dominik Naessens, Chris Cameron & David C. Hoaglin. (2021) Network Meta-analysis of Ulcerative Colitis Pharmacotherapies: Carryover Effects From Induction and Bias of the Results. Clinical Gastroenterology and Hepatology 19:10, pages 2219-2221.
Crossref
D. I. Abdulganieva, A. L. Bakulev, E. A. Belousova, A. V. Veselov, T. V. Korotaeva, A. M. Lila, E. Yu. Loginova, E. V. Sokolovskiy, M. M. Khobeysh, M. V. Shapina & O. B. Shchukina. (2020) Early administration of genetically engineered biological agents for immune-mediated inflammatory diseases: opportunities and prospects. An experts’ opinion. Almanac of Clinical Medicine 48:6, pages 422-436.
Crossref
D. I. Abdulganieva, A. L. Bakulev, E. A. Belousova, A. V. Veselov, T. V. Korotaeva, A. M. Lila, E. Yu. Loginova, E. V. Sokolovskiy, M. M. Khobeish, M. V. Shapina & O. B. Shchukina. (2020) Early prescription of biological agents for immune-mediated inflammatory diseases: opportunities and prospects. An expert’s opinion. Modern Rheumatology Journal 14:3, pages 7-18.
Crossref
L. S. Kruglova, A. N. Lvov, A. V. Kagramanova & O. V. Knyazev. (2019) Psoriasis and inflammatory bowel diseases: pathogenetic pathways and the choice of biologic therapy (a literature review). Almanac of Clinical Medicine 47:6, pages 568-578.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.